ID   1207
AC   CVCL_VL59
DR   Wikidata; Q93297837
RX   PubMed=9139855;
RX   PubMed=29732388;
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
DI   NCIt; C4912; Bladder carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 07-09-18; Last updated: 29-06-23; Version: 5
//
RX   PubMed=9139855; DOI=10.1002/(SICI)1097-0215(19970410)71:2<284::AID-IJC25>3.0.CO;2-G;
RA   De Boer W.I., Houtsmuller A.B., Izadifar V., Muscatelli-Groux B.,
RA   van der Kwast T.H., Chopin D.K.;
RT   "Expression and functions of EGF, FGF and TGFbeta-growth-factor family
RT   members and their receptors in invasive human
RT   transitional-cell-carcinoma cells.";
RL   Int. J. Cancer 71:284-291(1997).
//
RX   PubMed=29732388; DOI=10.3233/BLC-180167; PMCID=PMC5929350;
RA   Zuiverloon T.C.M., de Jong F.C., Costello J.C., Theodorescu D.;
RT   "Systematic review: characteristics and preclinical uses of bladder
RT   cancer cell lines.";
RL   Bladder Cancer 4:169-183(2018).
//